Implicit Bioscience
Implicit Bioscience
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients | Lung Injury, Respiration Disorders, acute lung injury, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder | Recruiting | Phase 2 | 2026-07-29 | NCT06513949 | |
| Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-27 | NCT06678074 | |
| IC14 for Treatment of Acute Decompensated Heart Failure | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-27 | NCT06556810 |